Cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness.

Military Medicine
Leann A LovejoyRachel E Ellsworth

Abstract

The majority of active duty service women (ADS) are young, have access to healthcare, and meet fitness standards set by the U.S. military, suggesting that ADS represent a healthy population at low risk of cancer. Breast cancer is, however, the most common cancer in ADS and may have a significant effect on troop readiness with lengthy absence during treatment and inability to return to duty after the treatment. The identification of unaffected ADS who carry germline mutations in cancer predisposition genes ("previvors") would provide the opportunity to prevent or detect cancer at an early stage, thus minimizing effects on troop readiness. In this study, we determined (1) how many high-risk ADS without cancer pursued genetic testing, (2) how many previvors employed risk-reducing strategies, and (3) the number of undiagnosed previvors within an ADS population. The Clinical Breast Care Project (protocol WRNMMC IRB #20704) database of the Murtha Cancer Center/Walter Reed National Military Medical Center was queried to identify all ADS with no current or previous history of cancer. Classification as high genetic risk was calculated using National Comprehensive Cancer Network 2019 guidelines for genetic testing for breast, ovary, colo...Continue Reading

References

May 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A J NixonJ R Harris
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Lisa A CareyRobert C Millikan
Jun 10, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kangmin ZhuKatherine A McGlynn
Sep 3, 2010·JAMA : the Journal of the American Medical Association·Susan M DomchekTimothy R Rebbeck
Feb 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karen H LuUNKNOWN American Society of Clinical Oncology
Sep 10, 2014·JAMA : the Journal of the American Medical Association·Mary-Claire KingAmnon Lahad
Oct 15, 2014·Breast Cancer Research and Treatment·Xinglei ChaiTimothy R Rebbeck
Dec 3, 2016·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Elvira D'AndreaPaolo Villari
Sep 22, 2018·Oncotarget·Ranjit Manchanda, Rosa Legood
Dec 24, 2018·Cancers·Joanne Kotsopoulos
Feb 13, 2019·Journal of the National Cancer Institute·Sarah KnerrKaren J Wernli
Apr 12, 2019·British Journal of Cancer·Kelly MetcalfeUNKNOWN Hereditary Breast Cancer Clinical Study Group
Dec 23, 2019·The Breast Journal·Marie E WoodIsabelle Bedrosian
May 20, 2020·International Journal of Technology Assessment in Health Care·Manjusha HurryPaul Hoskins

❮ Previous
Next ❯

Software Mentioned

Variant Interpreter

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Related Papers

Canadian Medical Association Journal
The Journal of the American Dental Association
R H Scholle
Clinical & Developmental Immunology
Juan-Manuel AnayaJohn Castiblanco
© 2021 Meta ULC. All rights reserved